Modular Study to Evaluate CT7001 Alone in Cancer Patients With Advanced Malignancies

Clinical trial NCT03363893 · COMPLETED

Trial details

NCT number: NCT03363893
Sponsor: Carrick Therapeutics Limited
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Malignancies

Start date: 2017-11-14
Primary completion: 2022-12-15
Enrollment: 124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.